Femasys

NEWS

Pictured: IVF collage/Nicole Bean for BioSpace

Policy

Alabama Ruling, Political Blowback Rattle In Vitro Fertilization Market

A controversial decision by the Alabama Supreme Court temporarily chilled IVF before igniting nationwide pushes to protect access to this type of fertility treatment, leaving drugmakers with questions.

March 12, 2024

5 min read

Neil Versel

IN THE PRESS

Policy

Femasys Inc. Obtains Medical Device Establishment License from Health Canada

August 31, 2023

4 min read

Business

Femasys Inc. Announces Financial Results for the Second Quarter Ended June 30, 2023 and Provides Corporate Update

August 10, 2023

15 min read

Femasys Initiates Enrollment in Pivotal Trial of its Permanent Birth Control Candidate FemBloc- First of its kind, non-surgical, permanent birth control option begins enrollment in landmark trial -

August 3, 2023

6 min read

Policy

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control

July 27, 2023

4 min read

FDA

Femasys Announces FDA Approval of its IDE for the Pivotal Clinical Trial of FemBloc Permanent Birth Control, a Non-Surgical Alternative for Women

June 26, 2023

5 min read

Business

Femasys Inc. Replaces Two Board Members with Seasoned Industry Leaders in the Life Sciences

June 15, 2023

5 min read

Femasys to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023

June 14, 2023

1 min read

Femasys’ FemCath Intrauterine Catheter Receives Product Approval in Canada

June 8, 2023

5 min read

Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting

May 11, 2023

4 min read

Femasys’ FemCerv Endocervical Tissue Sampler for Cervical Cancer Diagnosis Receives Product Approval in Canada

May 3, 2023

4 min read

AWARDS

JOBS